INTRODUCTION
Primary hyperparathyroidism (PHPT) is described as elevated levels of serum calcium and parathyroid hormone (PTH) 1 . The incidence of PHPT is increasing substantially in countries that laboratory screening . However, high-density lipoprotein cholesterol (HDL-C) interferes with the effects of monocytes, which decreases the risk of cardiovascular diseases (CVD) 5, 6 . There is increasing interest in describing novel prognostic markers to facilitate the categorization of patients who have a greater risk for CVD. The monocyte count to HDL-C ratio (MHR) was postulated as a novel marker of prognosis for the development of future CVD 7, 8 . A growing body of evidence supports that even mild PHPT has an elevated risk for CVD [9] [10] [11] [12] [13] .
ABSTRACT

The monocyte count to HDL-Cholesterol ratio (MHR) has been shown as a novel prognostic indicator of cardiovascular diseases. Several studies demonstrated that even mild primary hyperparathyroidism (PHPT) has an increased risk for cardiovascular disease. We aimed to evaluate MHR and its relation with cardiometabolic risk factors in patients with PHPT. Seventy-five patients with PHPT and 96 control subjects were included in the study. Demographic, anthropometric, and biochemistry results were recorded. The groups were compared in terms of monocyte counts, HDL-cholesterol (HDL-C), and MHR values. Correlation analysis was used to determine the relation between MHR
We investigated the MHR and its relation to cardiometabolic risk factors in patients with PHPT.
MATERIAL and METHOD
Patient selection
Seventy-five patients who were diagnosed as having PHPT at Diskapi Training and Research Hospital between 2012 and 2016 and 96 controls were included in the study. Local ethics committee approval (06.11.2017-42/14) from Diskapi Training and Research Hospital was obtained and all participants provided written informed consent before the study began. Patients with multiple endocrine neoplasias, parathyroid cancer, thyroid cancer, hyperparathyroidismjaw tumor syndrome, and patients on drugs that counteract with calcium and vitamin D metabolism were excluded from the study. Diagnosis PHPT was defied as persistent hypercalcemia with normal or non-suppressed PTH concentrations 14 .
Clinical, biochemical and hormonal measurements
Basal demographic data, clinical features, carotid intima media thickness (CIMT) measurements were recorded for all participants. Weight, height, circumferences of waist (WC), body mass index (BMI), and systolic and diastolic blood pressure (SDP and DBP, respectively) were measured. Fasting state biochemical and hormonal measurements were performed in the morning using colorimetric methods and complete blood counts were obtained from all participants. An intact chemiluminescent immunoassay of PTH (Immulite 2000) was used to measure serum PTH levels. 25-OH vitamin D concentrations were measured using a radioimmune assay.
High-resolution B-mode ultrasound (EUB 7000 HV; Hitachi, Tokyo, Japan) with a 13-MHz linear array transducer was used to image parathyroids. Carotid intima-media thickness (CIMT) was measured to assess carotid atherosclerosis. In healthy middle-aged individuals, CIMT between 0.6 and 0.7 mm is accepted as normal, however, CIMT of ≥1 mm is associated with higher risk for CVD 15 . CIMT was measured by a B-mode imaging high-resolution ultrasound (EUB 7000 HV; Hitachi, Tokyo, Japan). CIMT was described as the distance between the blood-intima and media-adventitia boundaries on B-mode imaging high-resolution ultrasound system. All ultrasonographic measurements were performed by the same investigator (MC).
Statistical analysis
All statistical analyses were performed by using the JMP 13.0.1 software (SAS Institute, Cary, NC, USA). Quantitative data are expressed as mean ± standard deviation, or counts and proportions for categorical data. Normality of distribution was examined by using the Kolmogorov-Smirnov or Shapiro-Wilk W test. The chi-square or Fisher's exact test was used when variables are categorical. Student's t-test was used for normally distributed continuous variables and the Mann-Whitney U test for those that did not fit normal distribution. Correlations were assessed using Pearson's and Spearman's correlation. A p value lower than 0.05 was accepted statistically significant.
RESULTS
Seventy-five patients with PHPT and 96 controls were enrolled in the study. The mean age was similar in both groups (52.69±10.91 vs 53.33±7.70 years, p=0.667). Sex distribution and BMI was similar in each group (p=0.081 and p=0.159, respectively). White blood cell count, vitamin D, fasting plasma glucose, creatinine, HDL-C, LDL-C, triglyceride and C-reactive protein (CRP) levels were similar between the groups. SBP and DBP, calcium, and parathormone levels were higher in the PHPT group (p<0.0001). Phosphorous levels were significantly lower in the PHPT group (p<0.0001). CIMT and HOMA-IR were increased in the PHPT group (p<0.05). Monocyte counts and HDL-C levels were similar in both gro- (Table 2 ).
DISCUSSION
Our aim was to evaluate the correlation between 
Abbreviations: BMI=body mass index; CIMT=carotid intimamedia thickness; CRP=C-reactive protein; HOMA-IR=homeostasis model assessment of insulin resistance
MHR and cardiovascular risk factors in PHPT patients. MHR was correlated with SBP and HOMA-IR; however, it was not correlated with other cardiometabolic risk factors including DBP, CRP, and CIMT. We believe that ours is the first to evaluate the relationship between the MHR and cardiovascular risk factors in PHPT.
Monocytes migrate into tissue macrophages in interaction with platelets and endothelium, which exacerbates inflammation 4 . The monocyte count was demonstrated to predict the premature occurrence of coronary events, and the activation of monocytes is a key process in the beginning of atherosclerosis 16, 17 . HDL-C exhibits anti-inflammatory, antioxidant, and anti-platelet effects via several pathways, including contribution to the cholesterol outflow from macrophages, inhibition of endothelial adhesion protein expression, and encouraging reverse transport of oxidized molecules
18
. HDL-cholesterol inhibits monocyte activities and interrupts the transformation of monocytes to macrophages, which decreases inflammation 5 . As a consequence, combining measurements of HDL-C and monocyte counts as the MHR might represent the basic inflammatory process.
The significance of MHR in CVD risk estimation has been evaluated in several diseases. Kanbay et al. 19 first showed that increased MHR might predict CVD in chronic renal failure. Canpolat et al. 20 reported that pre-ablation MHR was related with recurrence of atrial fibrillation following catheter ablation using cryoballoon. Pre-procedural MHR was demonstrated to be related to slow coronary flow and serious in-hospital adverse cardiac events and mortality following angiographic intervention in ST-segment elevation myocardial infarction (STEMI) 20, 21 . Cetin et al. 8 found that MHR could predict stent thrombosis following angiographic intervention for STE-MI. Bolayir et al. 22 showed that an increased MHR independently predicted 30-day mortality in acute ischemic stroke. Cardiomyocytes, endothelial cells, and smooth muscle cells have PTH receptors 23 , and increased PTH has been associated with myocardial fibrosis, calcification, and hypertrophy 24 . Several studies showed that PHPT had increased cardiovascular events and mortality, many of which improved after parathyroidectomy [9] [10] [11] [12] [13] . Hypertension, hyperlipidemia, CIMT, CRP, and insulin resistance are all well-studied CVD risk factors 25, 26 . Patients with PHPT have a higher risk for CVD and these patients have increased cardiovascular-related mortality 27 . Various risk factors for CVD have been shown in patients with PHPT, including hypertension, and elevated CIMT, insulin resistance, and CRP [28] [29] [30] [31] . In the light of this information, we aimed to investigate whether MHR could be related to cardio-metabolic risk factors in patients with PHPT. Monocyte count, HDL-C levels and MHR did not differ between groups. We found a correlation between MHR and SBP and HOMA-IR; however, MHR was not correlated with other cardio-metabolic risk factors.
Hypertension (HT) leads to tissue damage in the heart and vessels, asymptomatic atherosclerosis and additional organ dysfunction demonstrated that MHR was associated with silent organ damage in HT. We observed that MHR and SBP were positively correlated, which might support the results of this study. Several studies showed that PHPT is associated with insulin resistance and increased incidence of prediabetes and diabetes 34, 35 . We found a correlation between MHR and HOMA-IR, which might support these results.
The findings of our study might be explained by many of our patients possibly being in the early stage of the disease, which might explain why MHR does not represent an association with all cardio-metabolic risk factors. This constitutes a possible limitation of the study. As another limitation it was a single-center study with a small sample size.
In conclusion, the MHR did not increase in patients with PHPT. The MHR correlated with SBP and HOMA-IR; however, it was not associated with other cardiometabolic risk factors including DBP, CIMT, and CRP. Our findings do not support the thesis of MHR as a potential marker of CVD in patients with PHPT. Nevertheless, its association with SBP and HOMA-IR might show the necessity for more comprehensive studies to enlighten this relation.
